Safety and Pharmacokinetics of Vaped Cannabis in Healthy Volunteers
Status:
Completed
Trial end date:
2018-11-24
Target enrollment:
Participant gender:
Summary
The primary objective of this study was to evaluate the pharmacokinetics (PK) of THC,
11-OH-THC and CBD following a single inhaled dose of PPP001 administered by vaporization.
The secondary objective of this study was to determine the safety and tolerability of THC and
CBD after a single inhaled dose of PPP001 administered by vaporization in healthy volunteers.